← Research.Patient.info
Browse research by treatment
1,000 treatments and interventions are being studied right now — from new medicines to therapies, devices and lifestyle programmes.
- Placebo6601206
- Pembrolizumab106210
- Carboplatin67138
- Cisplatin55118
- Paclitaxel42106
- Dexamethasone4890
- Cyclophosphamide3783
- Durvalumab3281
- Gemcitabine4077
- Bevacizumab4475
- Nivolumab3273
- Docetaxel3572
- ATEZOLIZUMAB2468
- Rituximab2767
- Pemetrexed2966
- Lenalidomide1958
- No Intervention4858
- Oxaliplatin2852
- Capecitabine2651
- Doxorubicin2346
- Prednisone1944
- Standard of Care2643
- Daratumumab2241
- MRI3340
- Questionnaires3439
- Blood sample3038
- Venetoclax2238
- Nab-paclitaxel1838
- Fludarabine1637
- Pomalidomide1937
- Olaparib1134
- Bortezomib1334
- Magnetic Resonance Imaging1933
- Fulvestrant1533
- Irinotecan2032
- Biospecimen Collection1632
- Enzalutamide1532
- Tocilizumab1731
- Etoposide1531
- Radiotherapy1431
- Cetuximab2031
- Obinutuzumab1230
- Leucovorin1930
- Abemaciclib928
- Vincristine1228
- Letrozole1328
- questionnaire2628
- Temozolomide1427
- Trastuzumab1226
- Radiation Therapy926
- Blood sampling2426
- Trastuzumab deruxtecan1525
- Palbociclib624
- Ribociclib1324
- Everolimus1224
- Exercise1724
- Control1523
- Fluorouracil1223
- Usual care1623
- Semaglutide923
- Ruxolitinib922
- Acalabrutinib922
- Rilvegostomig1721
- Cabozantinib821
- Computed Tomography921
- Azacitidine1221
- Sacituzumab tirumotecan1521
- DOSTARLIMAB821
- Epcoritamab421
- Carfilzomib920
- Cytarabine919
- Tirzepatide1319
- Data-collection1519
- quality-of-life assessment719
- CEMIPLIMAB919
- Ipilimumab919
- questionnaire administration919
- Teclistamab819
- Inavolisib1018
- Pumitamig1818
- Bendamustine918
- Upadacitinib618
- Risankizumab818
- 5-Fluorouracil1418
- Exemestane718
- This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.918
- Amivantamab818
- Laboratory Biomarker Analysis218
- Lenvatinib518
- Osimertinib317
- Methotrexate817
- Dupilumab517
- Guselkumab717
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended717
- Chemotherapy916
- Tremelimumab516
- Observation1216
- Zanubrutinib616
- Midazolam1016
- Niraparib616
- KEYTRUDA 25 mg/mL concentrate for solution for infusion1016
- Topotecan916
- Anastrozole516
- Prednisolone1216
- Trametinib615
- AVELUMAB415
- Belzutifan715
- TAMOXIFEN515
- Methylprednisolone614
- Blood samples1214
- Sunitinib714
- Metformin814
- ELRANATAMAB1114
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.414
- Abiraterone acetate414
- Rescue Medication1414
- Pirtobrutinib713
- Glofitamab613
- Talquetamab613
- Baricitinib1013
- IMFINZI 50 mg/mL concentrate for solution for infusion.713
- IBRUTINIB513
- Vinorelbine613
- Apalutamide412
- Abiraterone712
- Mirikizumab812
- Ocrelizumab212
- Bimekizumab812
- Deucravacitinib512
- Belantamab mafodotin512
- Matching Placebo712
- Control Group1012
- JNJ-77242113112
- Nipocalimab912
- Sonrotoclax711
- IMVT-1402811
- Capivasertib311
- Darolutamide711
- Ustekinumab311
- Blood test1111
- Giredestrant411
- volrustomig611
- Biopsy911
- Entrectinib310
- Iberdomide510
- ISATUXIMAB710
- Dacarbazine410
- Orforglipron510
- Pertuzumab410
- No Intervention: Observational Cohort1010
- Surgery610
- Observational810
- Dato-DXd410
- Adalimumab310
- Biopsy Procedure410
- Standard Care610
- Selinexor110
- Tacrolimus610
- Empagliflozin610
- Folfox910
- Enfortumab Vedotin310
- sotorasib610
- Afimkibart69
- Adagrasib79
- Filgotinib59
- Panitumumab89
- Tezepelumab49
- Alectinib39
- Virtual Reality79
- Radiation59
- Placebo Administration49
- Anakinra89
- Aspirin59
- Positron Emission Tomography69
- Apixaban49
- Eribulin39
- KarXT99
- normal saline79
- Psilocybin69
- Saline69
- Ifosfamide59
- Tucatinib39
- Cagrilintide39
- Efgartigimod PH20 SC49
- iptacopan59
- Placebo oral tablet59
- Polatuzumab Vedotin39
- sample collection99
- SBRT49
- Retatrutide29
- Linvoseltamab88
- Encorafenib48
- Luspatercept48
- Alpelisib38
- Prednisone/Prednisolone78
- Rivaroxaban58
- Odronextamab68
- Tislelizumab68
- Blinatumomab78
- Dasatinib48
- Dapagliflozin48
- Rescue Medications58
- Ianalumab28
- Surovatamig88
- Tarlatamab28
- Standard of care (SoC)68
- Inclisiran48
- Not applicable- observational study88
- zanidatamab68
- Mitapivat28
- Pulmonary vein isolation78
- Ramucirumab38
- folinic acid47
- Trifluridine-Tipiracil47
- Busulfan57
- Calderasib77
- LHRH Agonist17
- Amlitelimab7
- Zimberelimab7
- Echocardiogram77
- Elotuzumab37
- Teriflunomide17
- Biological collection77
- Lumbar puncture67
- Binimetinib57
- Etentamig57
- Sonelokimab37
- Sparsentan57
- NNC0487-011167
- Corticosteroids37
- Divarasib47
- Questionnaire and Physical Exam77
- Transcranial direct current stimulation77
- Tulisokibart47
- Camizestrant47
- Benralizumab37
- Temozolomide (TMZ)57
- The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.17
- Belimumab67
- Deucrictibant67
- Datopotamab Deruxtecan27
- Lazertinib27
- Cognitive Assessment67
- PET/MRI67
- platinum-based chemotherapy37
- Sacituzumab Govitecan67
- Secukinumab17
- ADT27
- Bariatric Surgery67
- Depemokimab47
- MRI Scan57
- Patritumab deruxtecan67
- Rilzabrutinib57
- The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date.57
- Blood sample collection77
- Diet77
- Sham (No Treatment)77
- Stereotactic Ablative Radiotherapy37
- Tiragolumab27
- Saruparib67
- Brentuximab vedotin36
- FOLFIRI66
- Elecoglipron66
- Breath test56
- Nemolizumab46
- Ipatasertib26
- Brenipatide66
- OPDIVO 10 mg/mL concentrate for solution for infusion.46
- APG77736
- Crizotinib26
- Sacituzumab Govitecan-hziy16
- Vinblastine46
- Domvanalimab6
- Vedolizumab56
- Lutikizumab16
- XBD17366
- Venepuncture46
- Whey protein56
- Ezabenlimab16
- Risdiplam46
- Exercise Training66
- levoleucovorin36
- Neuropsychological tests56
- Standard treatment56
- Time restricted eating66
- AZD139036
- Mosunetuzumab46
- Zanzalintinib56
- Tranexamic acid56
- 5-FU16
- Placebo IV46
- Atogepant46
- Azacitidine (AZA)56
- Cardiac MRI46
- Remibrutinib26
- INZ-70126
- Bone Scan56
- Not provided at time of registration6
- Echocardiography Test46
- Multigated Acquisition Scan36
- Telisotuzumab Adizutecan46
- Momelotinib56
- Pegcetacoplan36
- Placebo control56
- Melphalan46
- Lunsekimig46
- Pembrolizumab (KEYTRUDA®)46
- Nerandomilast46
- Intensity-Modulated Radiation Therapy26
- AMOXICILLIN36
- Anifrolumab56
- Cetrelimab16
- INDOCYANINE GREEN56
- Prehabilitation56
- Sham Procedure26
- Stereotactic body radiotherapy36
- survodutide46
- AZD012066
- Frexalimab36
- Gemcitabine + cisplatin16
- inulin66
- Non-Interventional46
- Non-Interventional Study56
- Observational study66
- Pemetrexed + carboplatin16
- Sotatercept26
- Trastuzumab emtansine16
- 5-fluorouracil (5-FU)66
- KETAMINE HYDROCHLORIDE46
- Maridebart Cafraglutide36
- Routine Care66
- Sham46
- Ceralasertib26
- Zilovertamab vedotin56
- Dexmedetomidine66
- Lebrikizumab36
- riliprubart66
- Itraconazole45
- Imatinib45
- Golcadomide25
- Androgen Deprivation Therapy (ADT)35
- Placebo Comparator45
- Vemurafenib25
- AZD98335
- Nivolumab + Relatlimab45
- Ravulizumab25
- Rosuvastatin45
- Futibatinib35
- Exercise Intervention45
- Inebilizumab45
- Furmonertinib5
- Colonoscopy55
- Revumenib35
- 177Lu-PSMA-61725
- Aerobic exercise45
- Botulinum toxin type A15
- daraxonrasib55
- Intismeran autogene25
- Dietary Intervention35
- Interview45
- Percutaneous coronary intervention45
- Photobiomodulation55
- Physiotherapy45
- Relatlimab35
- SGM-10155
- Transthoracic echocardiogram45
- Elritercept55
- Tecentriq 1 200 mg concentrate for solution for infusion45
- Placebo (matched to NNC0487-0111)45
- Lecanemab15
- Supportive care measures35
- Transcranial Magnetic Stimulation45
- Obexelimab15
- Selumetinib15
- Atomoxetine35
- vincristine sulfate5
- Capmatinib35
- Cobimetinib15
- Bone Marrow Aspiration25
- Stereotactic Body Radiation Therapy15
- Ultrasound35
- Emicizumab35
- Hydrocortisone35
- Oleclumab15
- Norepinephrine55
- Tebentafusp45
- Encorafenib + Binimetinib25
- Mavacamten25
- Mitomycin C35
- Zongertinib45
- Opevesostat45
- KarX-EC55
- Urine sample35
- Vehicle Cream45
- ASTX72735
- Axitinib5
- Barzolvolimab35
- brachytherapy25
- Catheter Ablation35
- Liver Biopsy45
- Magnetic Resonance Imaging (MRI)55
- Mycophenolate Mofetil55
- Quality of life questionnaires35
- Saliva sample25
- Smartwatch45
- Standard Care (in control arm)45
- Vicadrostat45
- AFLIBERCEPT45
- BLEOMYCIN25
- CEFAZOLIN45
- Elacestrant35
- Felzartamab35
- MEPOLIZUMAB15
- Pemetrexed + cisplatin15
- Placebo tablet35
- Radical prostatectomy15
- REGORAFENIB25
- Route of administration: oral use45
- Active surveillance35
- BCG35
- Colchicine45
- Ifinatamab deruxtecan45
- Radiofrequency Ablation45
- Placebo capsule35
- Ritlecitinib15
- [177Lu]Lu-NeoB14
- zolbetuximab24
- [68Ga]Ga-NeoB14
- AAA61724
- Anvumetostat4
- Bosutinib24
- Omeprazole34
- Bleximenib34
- Claseprubart24
- ENOXAPARIN34
- Efanesoctocog alfa24
- Plozasiran Injection4
- CGT948644
- AZD530514
- IPILIMUMAB, NIVOLUMAB4
- Itepekimab, Matched placebo for test product34
- Itepekimab (SAR440340)4
- Blood tests44
- SYT-51044
- Waiting list34
- LIBTAYO 350 mg concentrate for solution for infusion.14
- BHV-700024
- disitamab vedotin14
- AZD090124
- Pegylated liposomal doxorubicin (PLD)34
- Pelabresib34
- Finerenone (Kerendia, BAY94-8862)34
- Hydroxyurea34
- Ivosidenib44
- DOR/ISL4
- RCT21004
- LY353703144
- Escitalopram34
- Spirometry24
- ECG44
- Standard of care treatment34
- Ofatumumab24
- Nilotinib14
- Fianlimab4
- Bulevirtide14
- Electrical Impedance Tomography24
- Lutathera24
- Repetitive Transcranial Magnetic Stimulation (rTMS)44
- Idelalisib24
- Zasocitinib34
- Biofeedback training44
- Nirogacestat14
- Blood collection34
- glucose24
- goserelin24
- Imlunestrant14
- LEUCOVORIN CALCIUM4
- Lung ultrasound44
- Pacritinib34
- Paltusotine4
- Placebos44
- Protein supplement34
- psilocybin (25 mg)44
- Quality of Life44
- rapcabtagene autoleucel4
- stereotactic body radiotherapy (SBRT)34
- Belrestotug4
- Budigalimab24
- Pegaspargase14
- Nemtabrutinib34
- Pembrolizumab (+) Berahyaluronidase alfa24
- Tepotinib24
- The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full deta4
- RO72042394
- Rucaparib14
- Saline Nasal Spray44
- Satralizumab24
- TAR-2004
- YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.34
- Venetoclax (VEN)34
- Sorafenib4
- Selpercatinib4
- BI 7645324
- MEDI47364
- XEN110134
- Belumosudil34
- BMS-98650444
- Azithromycin34
- Chemotherapy drug44
- Cilta-cel4
- Daunorubicin34
- Bone Marrow Biopsy14
- Caffeine34
- RPT90444
- Hydroxychloroquine34
- Monalizumab14
- Bupropion34
- Sotagliflozin34
- Epoetin alfa24
- Faricimab4
- Lurbinectedin14
- Povetacicept14
- Cabazitaxel24
- Efgartigimod IV24
- Ontunisertib44
- povorcitinib14
- [177Lu]Lu-DOTA-TATE14
- Visugromab (CTL-002)34
- adjuvant therapy4
- Aortic valve replacement34
- Conduction system pacing44
- CTX00124
- dabrafenib24
- Electrocardiogram34
- Givinostat34
- golexanolone4
- Icotrokinra14
- JNJ-7963532234
- Lucerastat24
- Mezigdomide34
- Mitapivat-matching placebo4
- No Interventions44
- Optimal Medical Therapy24
- Pegylated liposomal doxorubicin34
- Placebo PH20 SC14
- Prostate Biopsy14
- Remdesivir44
- SODIUM CHLORIDE44
- T- Dxd24
- Transcranial direct current stimulation (tDCS)44
- Transthoracic echocardiography44
- tafasitamab4
- Treatment as Usual (TAU)34
- vosoritide24
- 68Ga-FAPI-464
- ALXN222014
- Fludeoxyglucose (18F)34
- Gemcitabine + carboplatin4
- JNJ-7893480424
- PF-0786848924
- Placebo semaglutide14
- Placebo Supplement34
- Ranibizumab24
- Sacituzumab govitecan-hziy (SG)14
- Sertraline34
- Sham Comparator34
- Tozorakimab34
- Axicabtagene Ciloleucel14
- CLOZAPINE34
- Datopotamab Deruxtecan (Dato-DXd)44
- Education34
- Non-invasive ventilation34
- Skin Biopsy34
- Degarelix14
- Cemdisiran24
- Apremilast34
- Tazemetostat14
- Sirolimus34
- Pozelimab24
- Forxiga 10 mg film-coated tablets24
- garadacimab34
- Gemtuzumab ozogamicin24
- Methylphenidate34
- Rapamune 1 mg/mL oral solution34
- Pazopanib4
- Vutrisiran23
- evorpacept13
- Radiprodil13
- Phesgo23
- Placebo matching Vicadrostat23
- Waitlist33
- Leniolisib3
- LP35213
- BGB-1141733
- Acalabrutinib (ACP-196)3
- CYB00323
- Trontinemab13
- Gazyvaro 1,000 mg concentrate for solution for infusion.3
- ALXN18503
- Probiotic33
Showing the top 600 of 1,000 matches — refine your search to narrow down.